In the intricate world of pharmaceutical manufacturing, the quality and availability of key intermediates are paramount. One such critical compound is 1-[4-[2-(diethylamino)ethoxy]phenyl]-1,2-diphenylethanol, known by its CAS number 73404-00-9. This molecule serves as a foundational component in the synthesis of Clomiphene Citrate, a widely recognized medication used to treat infertility in women by inducing ovulation. Understanding the production and properties of this intermediate is vital for pharmaceutical companies aiming for efficient and reliable drug synthesis.

NINGBO INNO PHARMCHEM CO.,LTD. is committed to supplying high-quality chemical intermediates, including 1-[4-[2-(diethylamino)ethoxy]phenyl]-1,2-diphenylethanol, to support the global pharmaceutical industry. The synthesis of Clomiphene Citrate from this precursor involves precise chemical reactions that demand intermediates with consistent purity and well-defined characteristics. The physical and chemical properties of 1-[4-[2-(diethylamino)ethoxy]phenyl]-1,2-diphenylethanol, such as its appearance as a light yellow or yellow solid and a purity of ≥98.0%, are crucial factors that influence the success of subsequent synthesis steps.

The chemical structure of 1-[4-[2-(diethylamino)ethoxy]phenyl]-1,2-diphenylethanol (Molecular Formula: C26H31NO2) makes it an ideal starting material for generating the desired pharmacological activity in Clomiphene Citrate. Pharmaceutical manufacturers often seek reliable suppliers who can ensure a consistent buy of this essential chemical intermediate. The ability to source this compound from a trusted manufacturer like NINGBO INNO PHARMCHEM CO.,LTD. directly impacts the efficiency and cost-effectiveness of Clomiphene Citrate production.

Furthermore, the research and development surrounding such intermediates often focus on optimizing the chemical synthesis to improve yields and reduce impurities. As a key building block in pharmaceutical synthesis, the demand for 1-[4-[2-(diethylamino)ethoxy]phenyl]-1,2-diphenylethanol remains steady, driven by the ongoing need for fertility treatments. NINGBO INNO PHARMCHEM CO.,LTD. plays a pivotal role in meeting this demand by providing a dependable supply chain for this vital pharmaceutical intermediate.